Denzil Bernard

Denzil Bernard is an experienced Director CADD at Atomwise, with a background as a Principal Scientist and Senior Scientist. Previously, Denzil worked as a Research Specialist at the University of Michigan, where they focused on the development of novel small molecule anti-cancer therapeutics and identification of new therapeutic targets. Denzil's expertise includes lead identification through various methods such as virtual screening, docking, and chemoinformatics, as well as lead optimization through rational structure-based design. With a PhD in Pharmaceutical Science from the University of Maryland Baltimore, Denzil has a strong educational background in pharmacy and a proven track record in medicinal chemistry and biochemistry.